Pyridine-4-sulfonamide → N-{[(2-{4-[5-Phenyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}ethyl)amino]carbonyl}pyridine-4-sulfonamide
Reaktionsgleichung
[C:1]1([C:7]2[N:11]([C:12]3[CH:17]=[CH:16][C:15]([CH2:18][CH2:19][NH:20][C:21](=O)[O:22]C4C=CC=CC=4)=[CH:14][CH:13]=3)[N:10]=[C:9]([C:30]([F:33])([F:32])[F:31])[CH:8]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[N:34]1[CH:39]=[CH:38][C:37]([S:40]([NH2:43])(=[O:42])=[O:41])=[CH:36][CH:35]=1>>[C:1]1([C:7]2[N:11]([C:12]3[CH:13]=[CH:14][C:15]([CH2:18][CH2:19][NH:20][C:21]([NH:43][S:40]([C:37]4[CH:38]=[CH:39][N:34]=[CH:35][CH:36]=4)(=[O:42])=[O:41])=[O:22])=[CH:16][CH:17]=3)[N:10]=[C:9]([C:30]([F:31])([F:32])[F:33])[CH:8]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1Komponenten
3
Versuchsvorschrift
The title compound was prepared according to the procedure described in step 1 of Example 42 from phenyl 2-{4-[5-phenyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}ethylcarbamate (step 4 of Example 78) and pyridine-4-sulfonamide: 1H-NMR (CDCl3) δ 8.79-8.73 (2H, m), 7.64-7.62 (2H, m), 7.31-7.07 (9H, m), 6.76 (1H, s), 6.24 (1H, br.s), 3.46-3.37 (2H, m), 2.81-2.72 (2H, m).
Quellen und Nachweise
- ORD-Eintrag
- ord-9706bb9b34094b2d8cc0188cadf815dc